drugset / Trial / NCT03663478

Continuous TQL Block for Elective Cesarean Section

NCT03663478 ↗

Phase 4 Completed 32 enrolled Zealand University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study is to investigate whether it is possible to prolong time to first opioid with the TQL block by inserting catheters bilaterally, providing continuous analgesia, in patients undergoing elective CS. Our hypothesis is that it will be possible to significantly extend time to first opioid with the blockade by 66.6%, increasing it from a mean of 5.6 hours to a mean of 10 hours.

Timeline

Start
2018-09-04
Primary completion
2020-04-08
Completion
2020-04-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified 0.2 % —

Indications

No indication recorded.